Since there are some similar features between lung and oral cancers, such as the major risk factor being smoking, that both patient groups can be broadly divided into patients with risk factors and without risk factors and the major genetic change being a TP53 mutation, we mainly used the development of precision medicine in NSCLC to be a role model for developing precision medicine in oral cancer here. The gene discussed is TP53; the disease is lip and oral cavity carcinoma.